LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM

Reporting ownerCIK 0001882764

Benjamin Hohl

22 transactions in one company, from February 12, 2026 to September 17, 2026.

Transactions: 221 company
Bought · P: $0open market
Sold · S: $1.5Mopen market
Net: −$1.5Mnet selling

By company

Where this insider traded.

Company	Ticker	Trades	Bought	Sold
Enliven Therapeutics, Inc.	ELVN	22	—	$1.5M

All transactions

22 in total, newest filings first.

Company	Ticker	Insider	Date	Code	Shares	Price	Value
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFODERIV	Sep 17	MPLAN	3,982	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Sep 17	SPLAN	289	$51.49	$15K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Sep 17	SPLAN	2,194	$50.72	$111K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Sep 17	SPLAN	3,535	$50.03	$177K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Sep 17	MPLAN	3,982	$14.85	$59K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Aug 17	SPLAN	1,388	$59.35	$82K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Aug 17	SPLAN	4,630	$58.35	$270K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFODERIV	Jul 17	MPLAN	1,072	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	SPLAN	123	$53.87	$7K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	SPLAN	2,638	$53.38	$141K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	SPLAN	2,564	$52.32	$134K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	SPLAN	369	$51.48	$19K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	SPLAN	324	$49.97	$16K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jul 17	MPLAN	1,072	$2.48	$3K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFODERIV	Jun 17	MPLAN	6,018	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jun 17	SPLAN	1,238	$44.75	$55K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jun 17	SPLAN	3,401	$43.86	$149K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jun 17	SPLAN	1,379	$42.79	$59K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Jun 17	MPLAN	6,018	$2.48	$15K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Mar 6	S	10,000	$29.58	$296K
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFODERIV	Feb 12	A	150,000	$0.00	—?
Enliven Therapeutics, Inc.	ELVN	Benjamin HohlCFO	Feb 12	A	25,000	$0.00	—